CL2020000097A1 - Polypeptide molecule with enhanced dual specificity. - Google Patents

Polypeptide molecule with enhanced dual specificity.

Info

Publication number
CL2020000097A1
CL2020000097A1 CL2020000097A CL2020000097A CL2020000097A1 CL 2020000097 A1 CL2020000097 A1 CL 2020000097A1 CL 2020000097 A CL2020000097 A CL 2020000097A CL 2020000097 A CL2020000097 A CL 2020000097A CL 2020000097 A1 CL2020000097 A1 CL 2020000097A1
Authority
CL
Chile
Prior art keywords
lymphocyte
specific
cells
polypeptide molecule
union
Prior art date
Application number
CL2020000097A
Other languages
Spanish (es)
Inventor
Dominik Maurer
Sebastian Bunk
Martin Hofmann
Felix Unverdorben
Original Assignee
Immatics Biotechnologies Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE102017115966.5A external-priority patent/DE102017115966A1/en
Application filed by Immatics Biotechnologies Gmbh filed Critical Immatics Biotechnologies Gmbh
Publication of CL2020000097A1 publication Critical patent/CL2020000097A1/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA PRESENTE INVENCIÓN SE REFIERE A UNA MOLÉCULA DE POLIPÉPTIDO BIESPECÍFICA QUE COMPRENDE UNA PRIMERA CADENA POLIPEPTÍDICA Y UNA SEGUNDA CADENA POLIPEPTÍDICA QUE PROPORCIONA UNA REGIÓN DE UNIÓN DERIVADA DE UN RECEPTOR DE LINFOCITO T (TCR) QUE ES ESPECÍFICA PARA UN EPÍTOPO PEPTÍDICO VÍRICO ASOCIADO AL COMPLEJO PRINCIPAL DE HISTOCOMPATIBILIDAD (MHC), Y UNA REGIÓN DE UNIÓN DERIVADA DE UN ANTICUERPO CAPAZ DE RECLUTAR CÉLULAS EFECTORAS INMUNITARIAS HUMANAS MEDIANTE LA UNIÓN ESPECÍFICA A UN ANTÍGENO DE SUPERFICIE DE DICHAS CÉLULAS, ASÍ COMO MÉTODOS PARA FABRICAR LA MOLÉCULA DE POLIPÉPTIDO BIESPECÍFICA, Y USOS DE LA MISMA.THE PRESENT INVENTION REFERS TO A BI-SPECIFIC POLYPEPTIDE MOLECULE THAT COMPRISES A FIRST POLYPEPTIDE CHAIN AND A SECOND POLYPEPTIDE CHAIN THAT PROVIDES A BINDING REGION DERIVED FROM A LYMPHOCYTE RECEPTOR FOR UNIQUE TYPICAL EPYPHYPHIC TCRYPE LYMPHOCYTE (TCR) WHICH IS SPECIFIC TO THE LYMPHOCYTE LYMPHOCYTE RECEPTOR PRINCIPLE VEPÍTICO VEPÍFICO VEPÍTÍGOS OF HISTOCOMPATIBILITY (MHC), AND A REGION OF UNION DERIVED FROM AN ANTIBODY CAPABLE OF RECRUITING HUMAN IMMUNE EFFECTIVE CELLS THROUGH THE SPECIFIC UNION TO A SURFACE ANTIGEN OF SAID USED CELLS, AS WELL AS MULTIPLE POLYTICAL, USED MELOSPYPETIC CELLS SAME.

CL2020000097A 2017-07-14 2020-01-13 Polypeptide molecule with enhanced dual specificity. CL2020000097A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762532713P 2017-07-14 2017-07-14
DE102017115966.5A DE102017115966A1 (en) 2017-07-14 2017-07-14 Polypeptide molecule with improved dual specificity
DE102017119866 2017-08-30
US201862658318P 2018-04-16 2018-04-16
DE102018108995 2018-04-16

Publications (1)

Publication Number Publication Date
CL2020000097A1 true CL2020000097A1 (en) 2020-05-29

Family

ID=70848164

Family Applications (2)

Application Number Title Priority Date Filing Date
CL2020000098A CL2020000098A1 (en) 2017-07-14 2020-01-13 Polypeptide molecule with enhanced dual specificity.
CL2020000097A CL2020000097A1 (en) 2017-07-14 2020-01-13 Polypeptide molecule with enhanced dual specificity.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CL2020000098A CL2020000098A1 (en) 2017-07-14 2020-01-13 Polypeptide molecule with enhanced dual specificity.

Country Status (6)

Country Link
JP (1) JP2021019626A (en)
CL (2) CL2020000098A1 (en)
HR (1) HRP20210759T1 (en)
IL (2) IL272046A (en)
PH (2) PH12020500098A1 (en)
ZA (1) ZA202000636B (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014244286B2 (en) * 2013-03-14 2018-11-08 Duke University Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor

Also Published As

Publication number Publication date
PH12020500095A1 (en) 2020-12-07
ZA202000636B (en) 2021-07-28
CL2020000098A1 (en) 2020-05-29
JP2021019626A (en) 2021-02-18
IL272046A (en) 2020-03-31
HRP20210759T1 (en) 2021-06-11
IL272045A (en) 2020-03-31
PH12020500098A1 (en) 2020-12-07

Similar Documents

Publication Publication Date Title
CO2020001491A2 (en) Polypeptide molecule with enhanced dual specificity
CY1121962T1 (en) T CELL RECEPTORS
AR110676A1 (en) TREATMENT OF CANCER USING CHEMERIC ANTIGENS RECEPTORS
CL2018000461A1 (en) Bispecific antibodies with tetravalence for a co-stimulator fnt receptor.
CO2018001405A2 (en) Chimeric antigen receptor based on single domain antibodies
AR105433A1 (en) METHODS TO IMPROVE THE EFFECTIVENESS AND EXPANSION OF IMMUNE CELLS
MX2023006482A (en) Bispecific antibodies specific for a costimulatory tnf receptor.
GT201700162A (en) ANTI-CD3 ANTIBODIES, ANTI-CD123 ANTIBODIES AND BIESPECIFIC ANTIBODIES THAT SPECIFICALLY JOIN CD3 AND / OR CD123
EA201792467A1 (en) HETERODIMERNYE ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS
BR112018067458A2 (en) antibodies to tigit
CO2017006808A2 (en) Bcma chimeric antigen receptors
BR112018014760A2 (en) anti-ror1 antibodies, bispecific antibodies to ror1 x cd3 and methods of use
EA201791139A1 (en) HETERODIMERNYE ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS
AR104718A1 (en) RECEIVERS OF ANTI-GD3 SPECIFIC CHEMICAL ANTIGENS FOR IMMUNOTHERAPIES AGAINST CANCER
CO7111273A2 (en) CD47 antibodies and methods of use thereof
CO2019013654A2 (en) Chimeric antigen receptors targeting flt3
CL2018003515A1 (en) Anti-gitr antibodies and their uses.
GT201300233A (en) RECEIVERS OF SIMILAR T-CELLS TO SPECIFIC ANTIBODIES FOR A WT1 PEPTIDE PRESENTED BY HLA-A2
BR112017015287A2 (en) antibodies to fcrn and methods of using them
AR115052A1 (en) MULTI-SPECIFIC ANTIBODIES AND THE USE OF THEM
BR112022024228A2 (en) CONSTRUCTS FOR CHIMERIC ANTIGEN RECEPTORS
CO2018012497A2 (en) Interferon beta antibodies and uses thereof
CO2020014343A2 (en) Cd3-specific antibodies and their uses
CO2019003759A2 (en) Antibodies that bind to the zika virus envelope protein and uses thereof
AR112228A1 (en) POLYPEPTIDE MOLECULE WITH ENHANCED DUAL SPECIFICITY